Phio Announced Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamous Cell Carcinoma

Benzinga Newsdesk www.benzinga.com Positive 87.9%

Neg 0% Neu 0% Pos 87.9%

Comments

No comments yet. Be the first!